Biocryst Pharmaceuticals Inc (BCRX)

CIK 882796 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biocryst Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 2, 202640000882796-26-000061
Sep 2, 202640000882796-26-000063
Sep 2, 202640000882796-26-000059
Sep 2, 202640000882796-26-000065
Sep 2, 202640000882796-26-000057
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000919
Aug 7, 2026SCHEDULE 13G0000093751-26-000420
Aug 5, 2026S-80001171843-26-005245
Aug 5, 202610-Q0001628280-26-053300
Aug 5, 20268-K0001171843-26-005223
Aug 4, 20268-K/A0001171843-26-005168
Jun 29, 20268-K0001171843-26-004333
Jun 15, 202640000882796-26-000039
Jun 15, 202640000882796-26-000043
Jun 15, 202640000882796-26-000045
Jun 15, 202640000882796-26-000037
Jun 15, 202640000882796-26-000041
Jun 15, 202640000882796-26-000052
Jun 15, 202640000882796-26-000035
Jun 15, 202640000882796-26-000053
Jun 15, 202640000882796-26-000055
Jun 12, 20268-K0001171843-26-004096
Jun 2, 202640000882796-26-000033
Jun 2, 202640000882796-26-000029
Jun 2, 202640000882796-26-000027